Menu Search
Equities

Garofalo Health Care SpA

GHC:MIL

Garofalo Health Care SpA

Actions
Health CareHealth Care Providers
  • Price (EUR)5.00
  • Today's Change-0.08 / -1.57%
  • Shares traded13.75k
  • 1 Year change+18.20%
  • Beta0.4736
Data delayed at least 15 minutes, as of Aug 14 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Garofalo Health Care SpA is an Italy-based healthcare group. The Group manages facilities across northern and central Italy, both private and accredited, providing a wide range of services and specializations covering all sectors of the health and social care sectors, among others, medicine, surgery, cardiology, rehabilitation, extended and intensive care units, psychiatric and diagnostic centers. Additionally, the Company is active in the research field in collaboration with Italian and foreign research institutions and universities.

  • Revenue in EUR (TTM)395.67m
  • Net income in EUR22.17m
  • Incorporated--
  • Employees2.77k
More ▼

Institutional shareholders

9.14%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 29 Apr 20242.37m2.63%
Arca Fondi SGR SpAas of 28 Jun 20241.69m1.87%
Fideuram Asset Management SGR SpAas of 28 Jun 2024952.98k1.06%
Mediolanum Gestione Fondi SGRpAas of 29 Dec 2023876.86k0.97%
Algebris (UK) Ltd.as of 31 Dec 2023689.30k0.76%
Eurizon Capital SGR SpAas of 30 Jun 2021419.36k0.47%
Euromobiliare Asset Management SGR SpAas of 28 Jun 2024405.00k0.45%
Azimut Capital Management SGR SpAas of 31 Jul 2024315.42k0.35%
Ersel Asset Management SGR SpAas of 31 Dec 2023288.59k0.32%
Kairos Partners SGR SpAas of 30 Jun 2023244.35k0.27%
More ▼
Data from 31 Dec 2023 - 31 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.